(Q39034818)

8 September 2017

title

BST2/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface (English)

1 reference

8 September 2017

main subject

Human coronavirus 229E

0 references

1 reference

1 reference

human coronavirus

1 reference

Shiu-Mei Wang

1

1 reference

8 September 2017

Kuo-Jung Huang

series ordinal

2

1 reference

8 September 2017

Chin-Tien Wang

series ordinal

3

1 reference

8 September 2017

language of work or name

English

0 references

publication date

15 December 2013

1 reference

8 September 2017

1 reference

8 September 2017

volume

449

1 reference

8 September 2017

page(s)

287-296

1 reference

Antagonism to human BST-2/tetherin by Sendai virus glycoproteins

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

SARS coronavirus: a new challenge for prevention and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Hepatitis C virus: assembly and release of virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Influenza virus partially counteracts restriction imposed by tetherin/BST-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

The Genome sequence of the SARS-associated coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

The molecular biology of coronaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Herpesvirus assembly and egress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Tetherin inhibits HIV-1 release by directly tethering virions to cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Coronaviruses post-SARS: update on replication and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Interferon-inducible antiviral effectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Inhibition of Lassa and Marburg virus production by tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Tetherin: Holding On and Letting Go

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

BST-2/tetherin: structural biology, viral antagonism, and immunobiology of a potent host antiviral factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Budding capability of the influenza virus neuraminidase can be modulated by tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

Nef proteins from simian immunodeficiency viruses are tetherin antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

No novel coronaviruses identified in a large collection of human nasopharyngeal specimens using family-wide CODEHOP-based primers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.11.030

10.1016/J.VIROL.2013.11.030

7 January 2021

Identifiers

DOI

1 reference

8 September 2017

1 reference